Dr. Michaël Chassé brings his research program on Improving Neurological Death Diagnosis into the CN
Dr. Michaël Chassé, intensivist at le Centre Hospitalier Universitaire de Québec and clinical researcher at the Ottawa Hospital Research Institute, recently brough his CIHR funded study on "Improving Neurological Death Diagnosis" into the CNTRP as a new component of the Increasing Solid Organ and Hematopoietic Cell Donation Project (P2). The primary goal of this project is to improve the neurological death determination (NDD) process by establishing accurate ancillary test(s) as a reference standard(s) for NDD.
As a new project under the CNTRP, Dr. Chassé and his team will:
investigate the accuracy of currently used ancillary tests;
explore Canadian practitioners' views on the use of ancillary test for NDD, current NDD diagnostic practices and their own opinion regarding NDD;
understand clinician, families and caregivers’ satisfaction/dissatisfaction regarding the NDD process in Canada.
The ultimate goal of this project is to optimize the use of ancillary tests for the purpose of NDD and improve organ donor families’ and caregivers’ satisfaction regarding NDD.
On behalf of the CNTRP, we welcome Dr. Chassé and his program into the CNTRP and look forward to supporting this exciting research.